ST. LOUIS, MO—(BUSINESS WIRE)—September Sep. 26, 23—Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced that the U.S. Food…Original Article
FDA Accepts Defender Pharmaceuticals’ New Drug Application for Intranasal Scopolamine Gel
